FN2 Earnings Intelligence
Elevance Health Inc. income statement (quarterly)
Elevance Health Inc. (ELV) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $8,560 | $8,713 | $9,657 | $10,232 | $10,348 | - | - |
| + Debt | $28,538 | $31,353 | $31,492 | $30,669 | $30,382 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $49,776 | $50,711 | $50,181 | $50,474 | $51,429 | $49,321.7 | $50,533.8 |
| % Growth | - | - | - | - | - | - | 0.7% |
| Gross Profit | $44,483 | $45,331 | $44,718 | $44,982 | $45,789 | - | - |
| % Margin | 89.4% | 89.4% | 89.1% | 89.1% | 89.0% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $1,743 | $1,189 | $1,764 | $1,463 | $1,365 | - | - |
| % Margin | 3.5% | 2.3% | 3.5% | 2.9% | 2.7% | - | - |
| Diluted EPS | $7.72 | $5.32 | $8.00 | $6.71 | $6.27 | $2.10 | $12.38 |
| % Growth | - | - | - | - | - | - | 54.7% |
| Operating Cash Flow | - | - | $4,332 | - | - | - | - |
| CapEx | - | - | $235 | - | - | - | - |
| Free Cash Flow | - | - | $4,097 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 3/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $49,776 | $50,711 | $50,181 | $50,474 | $51,429 | $49,321.7 | $50,533.8 |
| Gross Profit | $44,483 | $45,331 | $44,718 | $44,982 | $45,789 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $1,743 | $1,189 | $1,764 | $1,463 | $1,365 | - | - |
| Diluted EPS | $7.72 | $5.32 | $8.00 | $6.71 | $6.27 | $2.10 | $12.38 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8,560 | $8,713 | $9,657 | $10,232 | $10,348 |
| Short-term Debt | $360 | $180 | $724 | $0 | $0 |
| Long-term Debt | $28,178 | $31,173 | $30,768 | $30,669 | $30,382 |
| Total Debt | $28,538 | $31,353 | $31,492 | $30,669 | $30,382 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $4,332 | - | - |
| Capital Expenditure | - | - | $235 | - | - |
| Free Cash Flow | - | - | $4,097 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 89.4% | 89.4% | 89.1% | 89.1% | 89.0% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 3.5% | 2.3% | 3.5% | 2.9% | 2.7% |
| FCF Margin | - | - | 8.2% | - | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the ELV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.